Alamar Biosciences, Inc.
A biotech company that makes ultra-sensitive tools for measuring proteins in blood and other samples. Its NULISA platform lets researchers spot tiny amounts of disease-linked proteins, helping with early cancer detection and drug development. Founded in 2018 by Yuling Luo, who previously co-founded Advanced Cell Diagnostics, Alamar is based in Fremont, California, and grew out of the "next chapter" of ultra-sensitive molecular detection work.
Granted 5.7K · Bought 235.3K
Bought 235.3K
Granted 76.5K
Granted 37.2K
Granted 37.2K
Granted 37.2K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Qiming Corporate GP VI, Ltd. +6 co-filers10% owner · 12 transactions | — | 10.59M | — | — | — |
| Naclerio NicholasDirector · 8 transactions | — | 10.38M | 5.7K | 235.3K | — |
| Naclerio Nicholas +4 co-filers10% owner · 7 transactions | — | 6.02M | — | 235.3K | — |
| Luo YulingChief Executive Officer, Director · 8 transactions | — | 5.89M | 76.5K | — | — |
| Chen ShipingChief Operating Officer, Director · 5 transactions | — | 1.45M | 37.2K | — | — |
| White Timothy OgdenPresident · 3 transactions | — | 491.8K | 37.2K | — | — |
| McAnear Justin J.Chief Financial Officer · 1 transaction | — | 37.2K | 37.2K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: +470.6K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.